Par Pharmaceutical (PRX) Tops Q1 EPS by 8c
Tweet Send to a FriendGet Alerts PRX Hot Sheet
Price: $49.98 --0%
Revenue Growth %: +31.3%
Financial Fact:
(Loss) income from discontinued operations: 0
Today's EPS Names:
NED, OESX, WSTL, More
Revenue Growth %: +31.3%
Financial Fact:
(Loss) income from discontinued operations: 0
Today's EPS Names:
NED, OESX, WSTL, More
Trade PRX Now!
Par Pharmaceutical (NYSE: PRX) reported Q1 EPS of $0.80, $0.08 better than the analyst estimate of $0.72. Revenue for the quarter came in at $271.5 million versus the consensus estimate of $230.84 million.
For earnings history and earnings-related data on Par Pharmaceutical (PRX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Par Pharmaceutical (PRX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- L Brands, Inc. (LTD) Tops Q1 EPS by 2c; Guides Q2, FY13 EPS
- Lowes Cos. (LOW) Misses Q1 EPS by 2c; Reaffirms FY13 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
